Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00002156 | A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) | PHASE2 | COMPLETED | 194 | — | — | - | - | Jun 24, 2005 | 18 | United States |
| NCT00002356 | The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes | PHASE2 | COMPLETED | - | — | — | - | - | Jun 24, 2005 | 25 | United States |
| Name | Type | Description |
|---|---|---|
| Fomivirsen sodium | DRUG | - |
| Ganciclovir | DRUG | - |
Inclusion Criteria Patients must have: * AIDS. * CMV retinitis that is not adequately controlled (previously diagnosed patients with smoldering CMV retinitis or those with active CMV retinitis borders on indirect ophthalmoscopy). * No more than one previous progression of CMV retinitis. Exclusion...